T. Faure

发表

Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.

P. Kourilsky, F. Quintin-Colonna, P. Devauchelle, 1996, Gene therapy.

A new recombinant procoagulant protein derived from the cDNA encoding human factor VIII.

T. Faure, C. Mazurier, P. Meulien, 1988, Protein engineering.

COMPARISON OF TWO SYSTEMS BASED ON POROUS BEADS FOR THE PRODUCTION OF RECOMBINANT VON WILLEBRAND FACTOR BY CHO CELLS

T. Faure, J. Jannin, F. Dhainaut, 1991 .

Characterisation of two differently processed forms of human recombinant factor IX synthesised in CHO cells transformed with a polycistronic vector.

H. de la Salle, A. Balland, T. Faure, 1988, European journal of biochemistry.

Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans‐immortalized hepatic cell lines.

A. Balland, T. Faure, A. Pavirani, 1990, The EMBO journal.

The influence of mRNA primary and secondary structure on human IFN-γ gene expression in E. coli

T. Faure, A. Benavente, J. Lecocq, 1984 .

Transgenic Animals as a Source of Genetically-Engineered Trans-Immortalised Cell Lines

A. Balland, T. Faure, A. Pavirani, 1991 .

Adrenalectomy decreases amino-acid transport in hepatocytes

T. Faure, J. Dolais-Kitabgi, A. L. Cam, 1981, Molecular and Cellular Endocrinology.

Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II.

H. de la Salle, P. Lepage, C. Roitsch, 1991, European journal of biochemistry.

Expression of Recombinant Factor VIII Molecules in Mammalian Cells

T. Faure, A. Pavirani, P. Meulien, 1990 .

Characterization of trans-immortalized hepatic cell lines established from transgenic mice.

T. Faure, A. Pavirani, F. Perraud, 1991, Experimental cell research.

Responses to interferon of LM cells growing continuously in the absence of serum and exogenous lipids.

B. Lebleu, T. Faure, P. Milhaud, 1983, The Journal of general virology.

Serum-Free Cultures of Mouse LM Fibroblasts as a Tool for Biochemical and Genetic Studies in the Cellular Responses to Interferon

B. Lebleu, T. Faure, P. Milhaud, 1983 .

Isolation and biological characterization of mouse LM fibroblast variants resistant to the cytotoxicity of polyriboinosinic polyribocytidylic acid after interferon treatment.

M. Silhol, B. Lebleu, G. Huez, 1984, The Journal of general virology.

Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus.

M. Kieny, S. Benichou, D. Dormont, 1992, AIDS research and human retroviruses.

Numerical tables for the direct estimation of virus titres by the maximum likelihood method

X. Milhaud, M. Silhol, T. Faure, 1983 .

In Vitro Carboxylation of a Blood Coagulation Factor IX Precursor Produced by Recombinant-DNA Technology

H. de la Salle, A. Balland, T. Faure, 1989, Thrombosis and Haemostasis.

Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.

T. Faure, M. Mehtali, A. Pavirani, 1996, Gene therapy.

Production of recombinant Von Willebrand factor by CHO cells cultured in macroporous microcarriers

T. Faure, A. Pavirani, B. Arbeille, 1990, Cytotechnology.